Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 18.13
-0.01 (-0.06%)
Apr 29, 2026, 3:00 PM CST
SHA:688276 Revenue
Changchun BCHT Biotechnology Co. had revenue of 147.35M CNY in the quarter ending March 31, 2026, a decrease of -9.21%. This brings the company's revenue in the last twelve months to 590.13M, down -47.36% year-over-year. In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 605.07M, down -50.77%.
Revenue (ttm)
590.13M
Revenue Growth
-47.36%
P/S Ratio
12.71
Revenue / Employee
463.21K
Employees
1,266
Market Cap
7.50B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dezhan Healthcare Company | 396.16M |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.32B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.50B |
| China Animal Husbandry Industry | 6.20B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Jiangsu Yahong Meditech | 277.12M |
| Guangxi Wuzhou Zhongheng Group | 1.75B |
| KPC Pharmaceuticals,Inc. | 5.80B |